rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1998-9-15
|
pubmed:abstractText |
Recent case reports suggest that a combination of the appetite suppressants fenfluramine and phentermine is associated with an increased risk of cardiac-valve regurgitation. There are also reports of valvular disorders in persons taking fenfluramine or dexfenfluramine alone, particularly for more than three months.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
339
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
719-24
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9731087-Adult,
pubmed-meshheading:9731087-Aged,
pubmed-meshheading:9731087-Aortic Valve Insufficiency,
pubmed-meshheading:9731087-Appetite Depressants,
pubmed-meshheading:9731087-Case-Control Studies,
pubmed-meshheading:9731087-Drug Combinations,
pubmed-meshheading:9731087-Female,
pubmed-meshheading:9731087-Fenfluramine,
pubmed-meshheading:9731087-Follow-Up Studies,
pubmed-meshheading:9731087-Humans,
pubmed-meshheading:9731087-Incidence,
pubmed-meshheading:9731087-Male,
pubmed-meshheading:9731087-Middle Aged,
pubmed-meshheading:9731087-Mitral Valve Insufficiency,
pubmed-meshheading:9731087-Obesity,
pubmed-meshheading:9731087-Phentermine,
pubmed-meshheading:9731087-Risk,
pubmed-meshheading:9731087-Survival Analysis
|
pubmed:year |
1998
|
pubmed:articleTitle |
A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
|
pubmed:affiliation |
Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA 02421, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|